- Home
- SPRU vs IMA Comparison
SPRU vs IMA Comparison
Compare SPRU & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPRU | IMA |
|---|---|---|
| Founded | 2008 | 2019 |
| Country | United States | United States |
| Employees | 159 | 15 |
| Industry | Auto Parts:O.E.M. | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.2M | 54.8M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | SPRU | IMA |
|---|---|---|
| Price | $2.82 | $5.70 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 48.2K | ★ 62.7K |
| Earning Date | 05-13-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $23,194,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 48.68 | N/A |
| 52 Week Low | $1.13 | $3.94 |
| 52 Week High | $6.75 | $17.50 |
Technical Indicators
Market Signals| Indicator | SPRU | IMA |
|---|---|---|
| Relative Strength Index (RSI) | 28.92 | 50.42 |
| Support Level | $2.51 | $5.23 |
| Resistance Level | $3.32 | $7.17 |
| Average True Range (ATR) | 0.21 | 0.40 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 10.57 | 57.42 |
Price Performance
Historical ComparisonAbout SPRU Spruce Power Holding Corporation
Spruce Power Holding Corp is an owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's customers are homeowners and the Company's core solar service offerings generate revenues through, the sale of electricity generated by its home solar energy systems to homeowners, third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and the servicing of those agreements for other institutional owners of home solar energy systems.
About IMA ImageneBio Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.